Dizal (jiangsu) Pharmaceutical Co. Ltd. Class ASSE: 688192

"DIZAL PHARMACEUTICAL CO., LTD."Announcement on Use of Temporarily Idle Self-owned Funds for Entrusted Wealth Management

Sep 30, 2026 · Issued by Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 30, 2026

Announcement on Use of Temporarily Idle Self-owned Funds for Entrusted Wealth Management

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A

"DIZAL PHARMACEUTICAL CO., LTD."Announcement on Shareholding Reduction Plan of Senior ExecutiveSep 25
"DIZAL PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Publication of Research Results on Birelentinib for the Treatment of Diffuse Large B-Cell Lymphoma in "Blood Cancer Journal"Sep 10
"DIZAL PHARMACEUTICAL CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the Innovative Drug IndustrySep 9
"DIZAL PHARMACEUTICAL CO., LTD."Announcement on Shareholding Reduction Plan of Directors and Senior ManagementSep 4

All Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A news releases